Neuroene Therapeutics Alternatives & Competitors

12 companies similar to Neuroene Therapeutics — Developing mitochondrial small molecule drugs for difficult to treat neurologica...

Zhimeng Biopharma

Actively advancing innovative small molecule treatments for neurological conditions like e...

7 Series B $492.00M

Biopharma Biotechnology +1

Rigel Pharmaceuticals Inc.

A biotechnology company dedicated to providing small molecule drugs that significantly imp...

272 Grant

South San Francisco, Unit...

Biotechnology Health Care +2

Immunic Therapeutics

Immunic is a biotechnology company developing small molecule therapies for chronic inflamm...

91 Post-IPO Equity $520.00M

United States

Biotechnology Health and Wellness +1

Zymeworks Inc.

Developing novel medicines for patients with difficult-to-treat cancers and other serious...

264 IPO $867.80M

Canada

Biotechnology Health and Wellness

Rival Readout

Competing with Neuroene Therapeutics? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

PharmAkea Therapeutics

Pioneering high-quality small molecule drug candidates for fibroproliferative diseases.

Series A $10.00M

Biotechnology Health and Wellness +1

Selene Therapeutics

Innovative small molecule inhibitors targeting mitochondrial enzymes to address refractory...

2-10 Seed

Biotechnology Health and Wellness

Aquinox Pharmaceuticals

Discovering and developing small molecule therapeutics to treat cancer and inflammatory di...

Post-IPO Equity $221.39M

Biotechnology Health Care +1

Stealth BioTherapeutics

Committed to Innovation in Mitochondrial Therapies

72 Post-IPO Equity $191.40M

Needham, United States

Biopharma Biotechnology +2

Nimbus Therapeutics

We develop breakthrough medicines for patients through precision small molecule design.

103 $637.00M

Boston, United States

Biotechnology Health Care +2

Disarm Therapeutics

Creating advanced therapeutics to combat axonal degeneration and treat neurological diseas...

Series A $30.00M

Biotechnology Health Care +1

BioCryst Pharmaceuticals, Inc.

We develop oral small-molecule and protein therapeutics to treat hereditary angioedema (HA...

608 Post-IPO Debt $1.65B

Durham, United States

Biotechnology Health and Wellness

MitoRx Therapeutics

Developing new treatments to restore healthy mitochondrial metabolism in patients living w...

19 Seed $4.00M

Oxford, United Kingdom

Biotechnology Health and Wellness

Frequently Asked Questions

Companies similar to Neuroene Therapeutics include Zhimeng Biopharma, Rigel Pharmaceuticals Inc., Immunic Therapeutics, Zymeworks Inc., PharmAkea Therapeutics. They work in Biotechnology and Health and Wellness.

Bounce Watch lists 12 companies that share Neuroene Therapeutics's industries and are closest to it in business tags, services, target customers, business model and size.

Neuroene Therapeutics is a biotechnology startup based in the United States, founded in 2015. The company's focus lies in developing mitochondrial small molecule drugs for difficult-to-treat neurological diseases. Their innovative approach targets a crucial area of unmet medical need, promising potential breakthroughs...

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Neuroene Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Neuroene Therapeutics Profile Zhimeng Biopharma Alternatives Rigel Pharmaceuticals Inc. Alternatives Immunic Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. The 11 companies listed here were last checked between 12 Sep 2024 and 18 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.